Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant for Alcohol Use Disorder
NCT07532252Phase 2Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jan 2027
- Primary completion
- Aug 2030
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Daridorexant with Placebo (2 arms). Primary endpoints: Total Sleep Time at 1 month, Alcohol Craving Visual Analogue Scale at 1 month and 2 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
daridorexant
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07532252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532252.